IFIMED

Pharmaceutical manufacturing and distribution services by IFIMED, focusing on innovative medicines and customer-centric healthcare solutions.

About IFIMED

IFIMED is a Healthcare company. Pharmaceutical manufacturing and distribution services by IFIMED, focusing on innovative medicines and customer-centric healthcare solutions. The company has 38 employees. Its Indian entity Ifimed Pharmaceuticals Private Limited reported revenue of β‚Ή6.26 Cr. IFIMED offers products and services including Medicines and Healthcare Solutions. Its focus areas include Medical Supplies, Healthcare Products, Innovative Medicines and Pharmaceuticals.

Company details

IFIMED is recognized as a pharmaceutical company that covers the entire value chain of the industry, with a track record being built in new markets and novel partnerships. A sustained focus is placed on customer-centricity and distinctive capabilities to deliver affordable and innovative medicines. Healthcare needs are addressed efficiently and effectively in both established and emerging markets through relationship-oriented marketing, aiming to transform into a major drug company that enhances global health outcomes.

Key Metrics
  • Indian entity revenue
    ₹6.26 Cr

    FY 2025 · +23% YoY

  • Indian entity net profit
    ₹9.1 Lakh

    FY 2025 · 1% margin

  • Indian entity EBITDA
    ₹39.6 Lakh

    FY 2025 · 6% margin

  • Employee Count
    38

Products & Services of IFIMED

IFIMED offers a comprehensive portfolio of products and services, including Medicines and Healthcare Solutions.

Medicines
Pharmaceutical Products

Medicines are provided by IFIMED to cover the full value chain of the pharmaceutical industry, focusing on affordable and innovative solutions for better health.

Healthcare Solutions
Medical Services

Healthcare solutions are supplied by IFIMED through customer-centric approaches and partnerships, aimed at meeting needs in established and emerging markets.

Board of directors of Ifimed Pharmaceuticals Private Limited (IFIMED)

Ifimed Pharmaceuticals Private Limited is the primary company behind IFIMED. The board of Ifimed Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Prabhudev Pavithra, appointed in 2012.

DirectorDesignationAppointedTenureEntity
Prabhudev Pavithra
DIN 05328985
Director09 Aug 201214 yrs 3 moIfimed Pharmaceuticals Private Limited
Anantharamaiah Sudeendra
DIN 05320830
Managing Director09 Aug 201214 yrs 3 moIfimed Pharmaceuticals Private Limited

Financials of IFIMED

Figures of Ifimed Pharmaceuticals Private Limited, the primary company behind IFIMED, for FY 2025. Revenue was ₹6.26 Cr (+23% year on year). Net profit was ₹9.1 Lakh (1% margin). EBITDA was ₹39.6 Lakh (6% margin). Revenue has grown at a compounded annual rate of +15% over three years and +21% over five years.

  • ₹6.26 CrRevenue · FY 2025 · +23% YoY
  • ₹9.1 LakhNet profit · 1% margin
  • ₹39.6 LakhEBITDA · 6% margin
  • ₹25 LakhPaid-up capital
  • 38Employees (provident fund records)
  • +15%Revenue CAGR, 3 years
  • +21%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Ifimed Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for IFIMED

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about IFIMED

IFIMED has 38 employees.

The primary company behind IFIMED, Ifimed Pharmaceuticals Private Limited, reported revenue of β‚Ή6.26 Cr for FY 2025, up 23% year on year.

IFIMED is recognized as a pharmaceutical company that covers the entire value chain of the industry, with a track record being built in new markets and novel partnerships. A sustained focus is placed on customer-centricity and distinctive capabilities to deliver affordable and innovative medicines. Healthcare needs are addressed efficiently and effectively in both established and emerging markets through relationship-oriented marketing, aiming to transform into a major drug company that enhances global health outcomes.

IFIMED offers Medicines and Healthcare Solutions.

IFIMED operates through Ifimed Pharmaceuticals Private Limited.

The legal entities of IFIMED currently have 2 directors, including Prabhudev Pavithra, Anantharamaiah Sudeendra.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available